Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: 2025 Eurostat Trade Data and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: 2025 Eurostat Trade Data and Economic Impact
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› Jiaxing
Clinical trial register · China

Clinical Trials in Jiaxing, 2026

Every study on the ClinicalTrials.gov registry that lists a site in China and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 19212 matching records held by the registry are in this view. Synced 10 Nov 2026, 03:17 UTC
19212
Studies in scope
all four open statuses
11805
Recruiting now
open to new participants
2029
Lead sponsors
across recruiting studies
Top sites
Beijing 5582 Shanghai 3880 Guangzhou 3354 Hangzhou 1824 Wuhan 1342
Narrow the registerReset
Recruitment status
Phase
Lead sponsor
Second Affiliated Hospital, Zhejiang University, School of Medicine7 Affiliated Hospital of Jiaxing University6 Zhejiang University3 AstraZeneca3 Changhai Hospital2
Site location
Beijing5582 Shanghai3880 Guangzhou3354 Hangzhou1824 Wuhan1342
All 625 locations
Target enrolment
to

Trials with a site in Jiaxing

37 of 19212 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Chinese sites
Start
Not yet open
Affiliated Hospital of Jiaxing University
Not applicable
110
Jiaxing
2026-10-15
Not yet open
Zhejiang University
Not applicable
166
Kaifeng, Nanchang, Aksu, Hangzhou, Jiaxing, Taizhou
2026-10-15
Not yet open
Video-guided Versus Conventional Right-sided Double-lumen Tube Placement for Thoracoscopic Surgery
NCT07849400Right-sided Double-lumen Tube Positioning, Lung Isolation During Thoracoscopic Surgery, One-lung Ventilation, Lung Cancer
Diansan Su
Not applicable
566
Hangzhou, Jiaxing
2026-10-01
Recruiting
Xiamen Amoytop Biotech Co., Ltd.
Not applicable
300
Beijing, Changsha, Chengdu, Guangzhou, Hefei, Jiaxing, Jining, Kunming
2026-09-26
Recruiting
AstraZeneca
Phase 3
1,330
Beijing, Changsha, Chengdu, Chongqing, Fuzhou, Guangzhou, Guiyang, Jiaxing
2026-09-15
Recruiting
AstraZeneca
Not applicable
540
Chengdu, Chifeng, Dongyang, Hefei, Hengyang, Heze, Jiaxing, Langfang
2026-09-05
By invitation
Affiliated Hospital of Jiaxing University
Not applicable
40
Jiaxing
2026-09-01
Recruiting
Second Affiliated Hospital, Zhejiang University, School of Medicine
Phase 2/3
150
Nanning, Hangzhou, Huzhou, Jiaxing, Ningbo, Taizhou, Beijing
2026-08-27
By invitation
Affiliated Hospital of Jiaxing University
Not applicable
80
Jiaxing
2026-08-01
Not yet open
Second Affiliated Hospital, Zhejiang University, School of Medicine
Not applicable
630
Guangzhou, Wuhan, Nanchang, Shanghai, Chengdu, Hangzhou, Huzhou, Jiaxing
2026-07-01
Recruiting
Video-guided Versus Conventional Right-sided Double-Lumen Tubes for One-Lung Ventilation in Thoracoscopic Surgery
NCT07362797Thoracoscopic Surgery, Double Lumen Tube Intubation, One-Lung Ventilation
Diansan Su
Not applicable
566
Hangzhou, Jiaxing
2026-05-30
Recruiting
IASO-782 in Systemic Lupus Erythematosus
NCT07483346SLE - Systemic Lupus Erythematosus
DrugIASO-782
Shanghai IASO Biotechnology Co., Ltd
Phase 1
20
Hangzhou, Huzhou, Jiaxing
2026-05-26
Not yet open
Effect of taVNS on Perioperative Anxiety in Major Abdominal Surgery
NCT07495163Perioperative Anxiety, Major Abdominal Surgery
Second Affiliated Hospital, Zhejiang University, School of Medicine
Not applicable
282
Huzhou, Jiaxing, Meicheng, Hangzhou
2026-05-01
Recruiting
Microbiome and Enteric Signatures in Sepsis-associated Hepatorenal Injury
NCT07735182Sepsis, Acute Kidney Injury Due to Sepsis, Gastrointestinal Microbiome, Sepsis-Associated Liver Injury
First Affiliated Hospital of Zhejiang University
Observational
1,000
Hangzhou, Jiaxing, Ningbo, Taizhou
2026-02-15
Not yet open
Second Affiliated Hospital, Zhejiang University, School of Medicine
Not applicable
848
Beijing, Huangshi, Wuhan, Xiangyang, Hangzhou, Jiaxing, Ningbo
2026-01-01
Recruiting
High-Flow Nasal Cannula for Preventing Hypoxia During Sedated Endoscopy in High-Risk Obstructive Sleep Apnea Patients
NCT07307560Hypoxia, Esophageal Cancer, Gastric Cancer (Diagnosis), Obstructive Sleep Apnea (OSA)
Zhejiang University
Not applicable
600
Hangzhou, Jiaxing, Quzhou
2025-12-21
Not yet open
Tianjin Medical University Cancer Institute and Hospital
Phase 2
188
Guangzhou, Shijiazhuang, Luoyang, Nanyang, Chengdu, Tianjin, Jiaxing
2025-12-15
Recruiting
Affiliated Hospital of Jiaxing University
Not applicable
60
Jiaxing
2025-09-29
Recruiting
Artificial Intelligence-powered Low-Dose Computed Tomography for Screening of Pancreatic Cancer
NCT07117045Pancreatic Cancer, Intraductal Papillary Mucinous Neoplasm, High-grade Pancreatic Intraepithelial Neoplasia, PDAC - Pancreatic Ductal Adenocarcinoma
Changhai Hospital
Observational
400,000
Shanghai, Jiaxing, Ningbo
2025-08-15
Recruiting
Zhejiang University
Observational
5,000
Hangzhou, Jiaxing, Lishui
2025-08-03
By invitation
Affiliated Hospital of Jiaxing University
Observational
60
Jiaxing
2025-05-01
Recruiting
Shanghai Pulmonary Hospital, Shanghai, China
Observational
1,500
Guiyang, Changchun, Jinan, Shanghai, Jiaxing
2025-04-06
Recruiting
Second Affiliated Hospital, Zhejiang University, School of Medicine
Phase 2
51
Hangzhou, Dongyang, Huzhou, Jiaxing, Lishui, Ningbo, Quzhou, Shaoxing
2025-03-11
Recruiting
Second Affiliated Hospital, Zhejiang University, School of Medicine
Phase 2
38
Yangzhou, Shanghai, Hangzhou, Huzhou, Jiaxing, Ningbo, Wenzhou
2025-01-06
By invitation
Affiliated Hospital of Jiaxing University
Not applicable
126
Jiaxing
2025-01-01
Active, closed
Boehringer Ingelheim
Phase 3
1,666
Beijing, Changsha, Chengdu, Guangzhou, Hangzhou, Hefei, Hohhot, Jiaxing
2024-09-26
Recruiting
AI-powered Early Detection for Pancreatic Cancer Via Non-contrast CT in Opportunistic Screening Cohort
NCT06638866Pancreatic Cancer, Pancreatic Ductal Adenocarcinoma, Pancreatic Intraepithelial Neoplasias, Intraductal Papillary Mucinous Neoplasm
Changhai Hospital
Observational
5,000
Shanghai, Jiaxing, Ningbo
2024-08-03
Recruiting
The Affiliated People's Hospital of Ningbo University
Phase 3
99
Dongyang, Hangzhou, Huzhou, Jiaxing, Jinhua, Lishui, Ningbo, Shaoxing
2024-08-01
Recruiting
The Affiliated People's Hospital of Ningbo University
Phase 3
99
Dongyang, Hangzhou, Huzhou, Jiaxing, Jinhua, Lishui, Ningbo, Shaoxing
2024-08
Active, closed
Liaoning Chengda Biotechnology CO., LTD
Phase 4
600
Jiaxing, Jinhua, Ningbo, Quzhou
2023-11-11
Active, closed
Janssen Research & Development, LLC
Phase 3
684
Beijing, Bengbu, Chengde, Chengdu, Jiaxing, Jinan, Nanchang, Nanyang
2023-10-12
Recruiting
First Affiliated Hospital of Zhejiang University
Observational
2,000
Hangzhou, Huzhou, Jiaxing, Lanxi, Lishui, Pinghu, Taizhou, Wenzhou
2023-09-25
Active, closed
Second Affiliated Hospital, Zhejiang University, School of Medicine
Not applicable
158
Hangzhou, Jiaxing, Jinhua, Ningbo, Yiwu
2023-04-01
Recruiting
Shanghai Tong Ren Hospital
Phase 2
58
Changzhou, Chengdu, Ch’ang-ch’un, Ha’erbin, Hefei, Jiaxing, Lanzhou, Ningbo
2023-02-20
Recruiting
Zhejiang Cancer Hospital
Phase 2
41
Hangzhou, Jiaxing, Jinhua, Lishui, Ningbo, Quzhou
2022-08-01
Active, closed
AstraZeneca
Phase 3
1,035
Beijing, Changsha, Chengdu, Chongqing, Guangzhou, Hangzhou, Harbin, Jiaxing
2022-03-25
Recruiting
xuexin he
Not applicable
183
Hangzhou, Jiaxing, Lishui
2020-05-09
Rows per page Showing 1–37 of 37
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Chinese investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 10 November 2026. https://priyalifescience.com/clinical-trials-china/city/jiaxing

Query this register directly
GET /api/trials?country=cn&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in China and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 19,212 studies in total at the last sync on 10 Nov 2026, 03:17 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 37 of those studies with a site in Jiaxing.

How many clinical trials are recruiting in Jiaxing?

21 of the 37 studies on this page are recruiting new participants as of the 10 Nov 2026, 03:17 UTC sync. A further 7 have not yet opened recruitment, 5 are active but closed to new participants, and 4 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Jiaxing), 37 studies
PhaseStudiesRecruitingShare
Not applicable16643.2%
Observational7618.9%
Phase 36316.2%
Phase 25413.5%
Phase 1112.7%
Phase 2/3112.7%
Phase 4102.7%

Most active sponsors

Lead sponsors with the most studies (Jiaxing)
Lead sponsorStudiesRecruiting
Second Affiliated Hospital, Zhejiang University, School of Medicine73
Affiliated Hospital of Jiaxing University61
AstraZeneca32
Zhejiang University32
Changhai Hospital22
Diansan Su21
First Affiliated Hospital of Zhejiang University22
The Affiliated People's Hospital of Ningbo University22
Boehringer Ingelheim10
Janssen Research & Development, LLC10
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and India registers.